Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity

v3.19.3.a.u2
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Preferred stock, shares outstanding, beginning of period at Dec. 31, 2016   6,600,000        
Series A Redeemable Convertible Preferred Stock, beginning of period at Dec. 31, 2016   $ 22,873        
Outstanding shares, beginning of period (in shares) at Dec. 31, 2016     78,571,158      
Outstanding balance, beginning of period at Dec. 31, 2016 $ 162,316   $ 79 $ 191,308 $ 0 $ (29,071)
Common stock issuance ESPP plan (in shares) 108,599   108,599      
Common stock issuance ESPP plan $ 844     844    
Issuance of Series A Preferred Stock (in shares)   264,000        
Stock issuance fees and expenses (218)     (218)    
Foreign currency translation adjustments 44       44  
Gain (loss) on effective cash flow hedge 230       230  
Issuance of restricted stock (in shares)     822,711      
Issuance of restricted stock, net of forfeitures $ 4,095   $ 1 4,094    
Issuance of stock for warrant exercises     364,600      
Issuance of common stock for stock options (in shares) 565,569   595,506      
Issuance of common stock for stock options $ 1,960     1,960    
Deemed dividends on preferred stock and amortization of beneficial conversion feature (9,742) $ 9,742   (9,742)    
ESPP expense 96 $ 0   96    
Stock compensation expense - options and restricted stock 6,345     6,345    
Net income (loss) (396)         (396)
Working capital adjustment related to acquisition 0          
Preferred stock, shares outstanding, end of period at Dec. 31, 2017   6,864,000        
Series A Redeemable Convertible Preferred Stock, end of period at Dec. 31, 2017   $ 32,615        
Outstanding shares, end of period (in shares) at Dec. 31, 2017     80,462,574      
Outstanding balance, end of period at Dec. 31, 2017 $ 171,962   $ 80 194,687 274 (23,079)
Common stock issuance ESPP plan (in shares) 113,503   117,146      
Common stock issuance ESPP plan $ 1,050     1,050    
Stock issuance fees and expenses (354)     (354)    
Foreign currency translation adjustments (122)       (68) (54)
Gain (loss) on effective cash flow hedge (785)       (785)  
Issuance of restricted stock (in shares)     62,182      
Issuance of restricted stock, net of forfeitures $ (297)     (297)    
Issuance of common stock for stock options (in shares) 1,570,211   1,553,544      
Issuance of common stock for stock options $ 8,598   $ 2 8,596    
Deemed dividends on preferred stock and amortization of beneficial conversion feature (5,208) $ 5,208   (5,208)    
ESPP expense 243     243    
Stock compensation expense - options and restricted stock 6,640     6,640    
Net income (loss) 2,640         2,640
Redemption of Series A Preferred stock (in shares)   (6,864,000)        
Redemption of Series A Preferred Stock (21,348) $ (37,823)   (21,348)    
Issuance of common stock - Acquisition (in shares)     999,994      
Issuance of common stock - Acquisition 13,243   $ 1 13,242    
Issuance of common stock - Public Offering (in shares)     11,270,000      
Issuance of common stock - Public Offering 135,071   $ 11 135,060    
Gain on redemption of preferred stock 9,075     9,075    
Working capital adjustment related to acquisition 0          
Preferred stock, shares outstanding, end of period at Dec. 31, 2018   0        
Series A Redeemable Convertible Preferred Stock, end of period at Dec. 31, 2018   $ 0        
Outstanding shares, end of period (in shares) at Dec. 31, 2018     94,465,440      
Outstanding balance, end of period at Dec. 31, 2018 $ 320,443   $ 94 340,291 (579) (19,363)
Common stock issuance ESPP plan (in shares) 141,908   141,908      
Common stock issuance ESPP plan $ 2,332     2,332    
Stock issuance fees and expenses (263)     (263)    
Gain (loss) on effective cash flow hedge (1,039)       (1,039)  
Issuance of restricted stock (in shares)     168,501      
Issuance of restricted stock, net of forfeitures $ (837)     (837)    
Issuance of common stock for stock options (in shares) 2,309,451   2,054,911      
Issuance of common stock for stock options $ 9,974   $ 3 9,971    
ESPP expense 609     609    
Stock compensation expense - options and restricted stock 9,386     9,386    
Net income (loss) 8,006         8,006
Issuance of common stock - Public Offering (in shares)     8,050,000      
Issuance of common stock - Public Offering 160,774   $ 8 160,766    
Working capital adjustment related to acquisition (in shares)     (99,524)      
Working capital adjustment related to acquisition (1,977)     (1,977)    
Preferred stock, shares outstanding, end of period at Dec. 31, 2019   0        
Series A Redeemable Convertible Preferred Stock, end of period at Dec. 31, 2019   $ 0        
Outstanding shares, end of period (in shares) at Dec. 31, 2019     104,781,236      
Outstanding balance, end of period at Dec. 31, 2019 $ 507,408   $ 105 $ 520,278 $ (1,618) $ (11,357)